Paid Clinical Trials in Rockville, MD
As of September 2026, 92 paid clinical trials are recruiting in Rockville, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Rockville offers studies at sites including Shady Grove Fertility for conditions such as Obesity, Overweight, Atopic Dermatitis, Plaque Psoriasis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Rockville
Trials by drug in Rockville
Filter results
Newly added in Rockville
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
84 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Brenipatide in Participants With Alcohol Use Disorder
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Top Research Study Locations in Rockville
Researchers run research studies in Rockville, MD at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Shady Grove Fertility | Azoospermia, Chaotic Aneuploidy, Complex Aneuploidy | 4 |
| Sunstone Medical, PC | Adjustment Disorders, Cancer, Major Depressive Disorder | 4 |
| Dermatology and Skin Cancer Specialists, LLC | Alopecia Areata, Overweight or Obesity, Plaque Psoriasis | 3 |
| Maryland Treatment Centers - Avery Road Treatment Center | Alcohol Use Disorder, Opioid Use Disorder | 3 |
| National Cancer Institute - Shady Grove | Capillary Arteriovenous Malformation Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome | 3 |
| Arthritis and Rheumatism Associates | Lupus Nephritis, Primary Sjogren's Disease, Polymyalgia Rheumatica | 3 |
| Velocity Clinical Research - Rockville | Atherosclerotic Cardiovascular Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 3 |
| Adventist HealthCare Shady Grove Medical Center | Cardiovascular Disease and Lipoprotein(a), Heart Failure, Obesity | 2 |
| All Natural Medicine Clinic, LLC | Acute Viral Respiratory Infection, Covid19 Virus Infection | 2 |
| GSK Investigational Site | Bronchiectasis, Pulmonary Disease, Chronic Obstructive | 2 |
| Lawrence J. Green, MD. LLC | Moderate to Severe Glabellar Lines, Plaque Psoriasis | 2 |
| Maryland Oncology Hematology, P.A. | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 2 |
| Shady Grove Fertility Rockville | Fertility Preservation, Fertilization in Vitro, Infertility, Female | 2 |
| Sunstone Therapies | Demoralization, Post Traumatic Stress Disorder | 2 |
| U.S. Dermatology Partners Rockville | Atopic Dermatitis, Plaque Psoriasis | 2 |
| Velocity Clinical Research, Rockville | Cortisol Excess, Obstructive Sleep Apnea (OSA), Type 2 Diabetes | 2 |
| Arthritis and Rheumatism Associates - Rockville | Radiographic Axial Spondyloarthritis, Psoriatic Arthritis | 2 |
| Galderma Investigational | Prurigo Nodularis, Atopic Dermatitis | 2 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Anthos Investigational | Atrial Fibrillation (AF) | 1 |
| Arthritis & Rheumatism Associates | Systemic Lupus Erythematosus (SLE) | 1 |
| Avery Road Treatment Center (ARTC) | Opioid-use Disorder | 1 |
| Biostatistics Center, George Washington University | Alzheimer Disease, Dementia, Dementia, Vascular | 1 |
| C.W. Bill Young Marrow Donor Center | Healthy | 1 |
Active & Upcoming Studies in Rockville (2026)
Recruiting trials in Rockville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (14 active studies)
- Clinical Genetics Branch Eligibility Screening Survey · National Cancer Institute (NCI)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
Diabetes & metabolic (12 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Cardiovascular (5 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Mental health & behavior (3 active studies)
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
- Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD · Phase 2 · Sunstone Medical
Neurology & pain (3 active studies)
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. · Phase 2 · Incannex Healthcare Ltd
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Eye & vision (2 active studies)
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study · Iantrek, Inc.
- Hydrus® Microstent New Enrollment Post-Approval Study · Alcon Research
Vaccines (1 active study)
- Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence · National Institute of Allergy and Infectious Diseases (NIAID)
Pediatric (1 active study)
Common conditions studied in Rockville
- Obesity (6 active studies)
- Overweight (4 active studies)
- Atopic Dermatitis (3 active studies)
- Plaque Psoriasis (3 active studies)
- Type 2 Diabetes (3 active studies)
- Alcohol Use Disorder (2 active studies)
Leading research sponsors in Rockville
- Eli Lilly and Company
- National Cancer Institute (NCI)
- Pfizer
- Merck Sharp & Dohme LLC
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Rockville?
There are approximately 92 recruiting clinical trials in Rockville, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rockville pay participants?
Most recruiting trials in Rockville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rockville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rockville?
The most common conditions under active study in Rockville include Obesity (6), Overweight (4), Atopic Dermatitis (3), Plaque Psoriasis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rockville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rockville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rockville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rockville?
Recruiting research sites in Rockville include Shady Grove Fertility, Sunstone Medical, PC, Dermatology and Skin Cancer Specialists, LLC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rockville right now?
The largest active categories in Rockville are Cancer & tumors (14), Diabetes & metabolic (12), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.